Jack Phillips - 30 Sep 2021 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Chief Executive Officer
Signature
/s/ Steven Reichling, attorney-in-fact
Issuer symbol
AXDX
Transactions as of
30 Sep 2021
Transactions value $
$33,331
Form type
4
Filing time
10 Dec 2021, 14:57:22 UTC
Previous filing
24 Jun 2021
Next filing
07 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Award $33.3K +4.34K +3.85% $7.68 117K 30 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares purchased by the reporting person from Accelerate Diagnostics, Inc. in connection with the closing of the third and final tranche of an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 promulgated thereunder. The third and final tranche of the offering closed on September 30, 2021.